These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia. Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593 [TBL] [Abstract][Full Text] [Related]
5. Similar verbal fluency patterns in amnestic mild cognitive impairment and Alzheimer's disease. Teng E; Leone-Friedman J; Lee GJ; Woo S; Apostolova LG; Harrell S; Ringman JM; Lu PH Arch Clin Neuropsychol; 2013 Aug; 28(5):400-10. PubMed ID: 23752677 [TBL] [Abstract][Full Text] [Related]
6. Clustering and switching during a semantic verbal fluency test contribute to differential diagnosis of cognitive impairment. Zhao Q; Guo Q; Hong Z Neurosci Bull; 2013 Feb; 29(1):75-82. PubMed ID: 23322003 [TBL] [Abstract][Full Text] [Related]
7. Lexical factors and cerebral regions influencing verbal fluency performance in MCI. Clark DG; Wadley VG; Kapur P; DeRamus TP; Singletary B; Nicholas AP; Blanton PD; Lokken K; Deshpande H; Marson D; Deutsch G Neuropsychologia; 2014 Feb; 54():98-111. PubMed ID: 24384308 [TBL] [Abstract][Full Text] [Related]
8. Irregular word reading as a marker of semantic decline in Alzheimer's disease: implications for premorbid intellectual ability measurement. Marier A; Dadar M; Bouhali F; Montembeault M; Alzheimers Res Ther; 2024 May; 16(1):96. PubMed ID: 38698406 [TBL] [Abstract][Full Text] [Related]
9. Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease. Collij LE; Heeman F; Kuijer JP; Ossenkoppele R; Benedictus MR; Möller C; Verfaillie SC; Sanz-Arigita EJ; van Berckel BN; van der Flier WM; Scheltens P; Barkhof F; Wink AM Radiology; 2016 Dec; 281(3):865-875. PubMed ID: 27383395 [TBL] [Abstract][Full Text] [Related]
10. Fully Automatic Speech-Based Analysis of the Semantic Verbal Fluency Task. König A; Linz N; Tröger J; Wolters M; Alexandersson J; Robert P Dement Geriatr Cogn Disord; 2018; 45(3-4):198-209. PubMed ID: 29886493 [TBL] [Abstract][Full Text] [Related]
11. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities. Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192 [TBL] [Abstract][Full Text] [Related]
12. Connected speech and language in mild cognitive impairment and Alzheimer's disease: A review of picture description tasks. Mueller KD; Hermann B; Mecollari J; Turkstra LS J Clin Exp Neuropsychol; 2018 Nov; 40(9):917-939. PubMed ID: 29669461 [TBL] [Abstract][Full Text] [Related]
13. COWAT Performance of Persons with Alzheimer Dementia, Vascular Dementia, and Parkinson Disease Dementia According to Stage of Cognitive Impairment. Lim KB; Kim J; Lee HJ; Yoo J; Kim HS; Kim C; Lee H PM R; 2019 Jul; 11(7):737-744. PubMed ID: 30746867 [TBL] [Abstract][Full Text] [Related]
14. Visual Rating and Computer-Assisted Analysis of FDG PET in the Prediction of Conversion to Alzheimer's Disease in Mild Cognitive Impairment. Kang JM; Lee JY; Kim YK; Sohn BK; Byun MS; Choi JE; Son SK; Im HJ; Lee JH; Ryu YH; Lee DY Mol Diagn Ther; 2018 Aug; 22(4):475-483. PubMed ID: 29761365 [TBL] [Abstract][Full Text] [Related]
15. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches. Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of abbreviated fluency measures in Alzheimer disease and vascular dementia. Canning SJ; Leach L; Stuss D; Ngo L; Black SE Neurology; 2004 Feb; 62(4):556-62. PubMed ID: 14981170 [TBL] [Abstract][Full Text] [Related]
17. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up. Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151 [TBL] [Abstract][Full Text] [Related]
18. Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment. Meghdadi AH; Stevanović Karić M; McConnell M; Rupp G; Richard C; Hamilton J; Salat D; Berka C PLoS One; 2021; 16(2):e0244180. PubMed ID: 33544703 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories. Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692 [TBL] [Abstract][Full Text] [Related]
20. Validity of the MemTrax Memory Test Compared to the Montreal Cognitive Assessment in the Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease in a Chinese Cohort. Liu X; Chen X; Zhou X; Shang Y; Xu F; Zhang J; He J; Zhao F; Du B; Wang X; Zhang Q; Zhang W; Bergeron MF; Ding T; Ashford JW; Zhong L J Alzheimers Dis; 2021; 80(3):1257-1267. PubMed ID: 33646151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]